GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] the UK — has anyone got a straight answer on ATTAIN — 19 comments in the full submission. View in context.
135
c/orforglipron·submitted 5 months ago by u/adaeze_cabrera

[Question] the UK — has anyone got a straight answer on ATTAIN

Questionbranch of 8 comments

Been lurking in c/t2dglp1 for about 5 months and finally have something worth posting. Short version: week 85, 2.5mg, and ATTAIN is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 31 threads, and the answers split roughly down the middle. What I actually want to know is…

Read the full submission and all 19 comments →

This branch

8 comments, started 5 months ago
u/marit_laurent13 points·5 months ago

Australia here. Waited 18 months on a list, gave up, went private, and the total cost was roughly what I expected.

replysharereportpermalink
u/neha_mwangi11 points·5 months ago·edited

Half-life is about 168 hours, so steady state lands around week 16–5. Practical consequence: what you feel in week 1 is not what that dose does.

replysharereportpermalink
u/discount_math_dm3 points·5 months ago·edited

Strongly agree. The supply impact would be huge.

replysharereportpermalink
u/niels_norgaard2 points·5 months ago

the nausea profile is speculative at this stage

replysharereportpermalink
u/dilara_weiss2 points·5 months ago

the supply conversation changes if this approves

replysharereportpermalink
u/declared_value_dv1 point·5 months ago

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink
u/fasting_insulin_f6 points·5 months ago

small molecule, not a peptide, purity discussion is different

replysharereportpermalink
u/fatima_kowalski2 points·5 months ago

small molecule, not a peptide, purity discussion is different

Adding to this: ATTAIN is doing more work than the comment implies.

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/orforglipron
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/phase_two_peteu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →